Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 27Unknown 6Active not recruiting 3Terminated 2Recruiting 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Hodgkin Disease 6Urinary Bladder Neoplasms 4Melanoma 2Lymphoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Seminoma 1Prostatic Neoplasms 1Endodermal Sinus Tumor 1Childhood Solid Tumor 1Carcinoma, Embryonal 1Bladder Adenocarcinoma 1

Interventions

Rituximab 66Cyclophosphamide 52fludarabine phosphate 26fludarabine 22Filgrastim 21Vincristine 19Methotrexate 19Melphalan 19Doxorubicin 18Radiotherapy 17Etoposide 17Prednisone 16Tacrolimus 15Whole-Body Irradiation 14Mycophenolic Acid 14Cytarabine 14Peripheral Blood Stem Cell Transplantation 13Gemcitabine 13Cyclosporine 13Antilymphocyte Serum 13Lenalidomide 12Busulfan 11Bortezomib 11Granulocyte Colony-Stimulating Factor 9Alemtuzumab 9sargramostim 8Dexamethasone 8Cord Blood Stem Cell Transplantation 8pembrolizumab 7ibritumomab tiuxetan 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Lymphoma × Vinblastine × Clear all
NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT00005090 2013-01-24

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

SWOG Cancer Research Network

Phase 3 Terminated
11 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡